Trade-offs between benefits and harms of drugs: a stated preference study with adult patients with cancer in Europe (Patient preferences)

First published 03/06/2021

Last updated 12/06/2024

EU PAS number:

EUPAS41433

Study

Finalised

Documents

Study protocol

Initial protocol

EMA patient preferences on benefits and harms of cancer drugs_Protocol_v3.0_Clean

English (1.09 MB - PDF) View document

Updated protocol

EMA patient preferences on benefits and harms of cancer drugs_Protocol 6 December 2021

First published: 22/02/2024

English (1.11 MB - PDF) View document

Study results

EMA patient preferences on benefits and harms of cancer drugs - Final Report v1.0 03May

English (1.72 MB - PDF) View document

Study report

Other information

Secondary tabs